Lonza Group Ag - 15 Year Stock Price History | LZAGY
Historical daily share price chart and data for Lonza Group Ag since 2011 adjusted for splits and dividends. The latest closing stock price for Lonza Group Ag as of September 16, 2026 is 65.28.
- The all-time high Lonza Group Ag stock closing price was 82.07 on August 27, 2021.
- The Lonza Group Ag 52-week high stock price is 74.00, which is 13.4% above the current share price.
- The Lonza Group Ag 52-week low stock price is 59.16, which is 9.4% below the current share price.
- The average Lonza Group Ag stock price for the last 52 weeks is 66.85.
| Lonza Group Ag Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 66.1264 | 67.3377 | 73.9660 | 58.5393 | 65.2800 | -2.82% |
| 2025 | 66.4792 | 57.8036 | 72.9903 | 55.2703 | 67.1764 | 15.63% |
| 2024 | 56.3998 | 40.6317 | 66.0353 | 39.5087 | 58.0974 | 41.80% |
| 2023 | 52.2592 | 47.6325 | 64.1384 | 33.6729 | 40.9700 | -13.69% |
| 2022 | 56.6427 | 78.6016 | 78.6016 | 43.0530 | 47.4658 | -41.08% |
| 2021 | 69.0215 | 61.6997 | 82.0664 | 53.7402 | 80.5600 | 30.57% |
| 2020 | 50.3258 | 34.7200 | 65.8352 | 31.3925 | 61.7006 | 77.57% |
| 2019 | 30.6915 | 24.3276 | 34.7924 | 24.3276 | 34.7467 | 42.46% |
| 2018 | 26.7884 | 25.2803 | 32.7870 | 21.3832 | 24.3908 | -3.29% |
| 2017 | 19.8725 | 13.6273 | 25.7023 | 13.6273 | 25.2206 | 83.43% |
| 2016 | 13.5877 | 12.4022 | 15.5867 | 10.8733 | 13.7494 | 8.29% |
| 2015 | 10.6281 | 8.5697 | 12.8346 | 8.2179 | 12.6967 | 47.34% |
| 2014 | 8.2071 | 6.9755 | 9.5876 | 6.8923 | 8.6170 | 21.96% |
| 2013 | 5.5452 | 3.8579 | 7.0884 | 3.8579 | 7.0654 | 83.45% |
| 2012 | 3.4113 | 4.2133 | 4.4790 | 2.4389 | 3.8515 | -4.01% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $45.867B | $7.881B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $177.122B | 19.46 |
| Medtronic (MDT) | Ireland | $118.448B | 16.19 |
| Stryker (SYK) | United States | $109.226B | 20.41 |
| EssilorLuxottica (ESLOY) | France | $77.130B | 0.00 |
| Boston Scientific (BSX) | United States | $63.636B | 13.68 |
| Medline (MDLN) | United States | $43.372B | 0.00 |
| Agilent Technologies (A) | United States | $43.330B | 25.36 |
| ResMed (RMD) | United States | $32.926B | 20.43 |
| GE HealthCare Technologies (GEHC) | United States | $28.678B | 13.71 |
| Koninklijke Philips (PHG) | Netherlands | $24.307B | 12.95 |
| Terumo (TRUMY) | Japan | $21.197B | 20.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.460B | 11.41 |
| Baxter (BAX) | United States | $12.165B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.674B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.135B | 40.84 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.751B | 23.95 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.562B | 20.19 |
| Raia Drogasil SA - (RADLY) | $5.056B | 0.00 | |
| BillionToOne (BLLN) | United States | $4.889B | 148.01 |
| Haemonetics (HAE) | United States | $4.834B | 21.21 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.011B | 16.99 |
| ICU Medical (ICUI) | United States | $3.890B | 23.23 |
| AtriCure (ATRC) | United States | $2.907B | 248.43 |
| Neogen (NEOG) | United States | $2.737B | 48.27 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.330B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.224B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.220B | 10.60 |
| GN Store Nord (GNNDY) | Denmark | $2.165B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.879B | 5.42 |
| LeMaitre Vascular (LMAT) | United States | $1.838B | 29.55 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.776B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.767B | 225.69 |
| Green Thumb Industries (GTBIF) | United States | $1.443B | 15.40 |
| Kestra Medical Technologies (KMTS) | United States | $1.434B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.433B | 11.00 |
| Omeros (OMER) | United States | $1.255B | 6.35 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.119B | 0.00 |
| CeriBell (CBLL) | United States | $0.940B | 0.00 |
| InMode (INMD) | Israel | $0.838B | 11.66 |
| AdaptHealth (AHCO) | United States | $0.806B | 16.89 |
| VAREX IMAGING (VREX) | United States | $0.778B | 17.10 |
| Glass House Brands (GLAS) | United States | $0.753B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.739B | 7.98 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.549B | 0.00 |
| Brainsway (BWAY) | Israel | $0.541B | 30.59 |
| Tilray Brands (TLRY) | Canada | $0.535B | 0.00 |
| Evolus (EOLS) | United States | $0.528B | 0.00 |
| Cerus (CERS) | United States | $0.510B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.498B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.441B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.411B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| Village Farms (VFF) | Canada | $0.346B | 15.72 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.83 |
| Sanara MedTech (SMTI) | United States | $0.323B | 159.54 |
| TriSalus Life Sciences (TLSI) | United States | $0.304B | 0.00 |
| MacroGenics (MGNX) | United States | $0.260B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.248B | 13.21 |
| OraSure Technologies (OSUR) | United States | $0.240B | 0.00 |
| High Tide (HITI) | Canada | $0.239B | 53.80 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.58 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.192B | 0.00 |
| Exagen (XGN) | United States | $0.188B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| Quanterix (QTRX) | United States | $0.138B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| FitLife Brands (FTLF) | United States | $0.088B | 11.51 |
| ImmuCell (ICCC) | United States | $0.087B | 120.12 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.082B | 4.65 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.048B | 3.94 |
| Nephros (NEPH) | United States | $0.047B | 39.09 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.58 |
| United-Guardian (UG) | United States | $0.033B | 13.20 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.019B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |